WO2015124113A1 - Semi-synthesis method for luteolin, galuteolin and luteolin rutinoside - Google Patents

Semi-synthesis method for luteolin, galuteolin and luteolin rutinoside Download PDF

Info

Publication number
WO2015124113A1
WO2015124113A1 PCT/CN2015/073238 CN2015073238W WO2015124113A1 WO 2015124113 A1 WO2015124113 A1 WO 2015124113A1 CN 2015073238 W CN2015073238 W CN 2015073238W WO 2015124113 A1 WO2015124113 A1 WO 2015124113A1
Authority
WO
WIPO (PCT)
Prior art keywords
luteolin
hesperetin
hesperidin
demethylation
dehydrogenation
Prior art date
Application number
PCT/CN2015/073238
Other languages
French (fr)
Chinese (zh)
Inventor
闻永举
Original Assignee
闻永举
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 闻永举 filed Critical 闻永举
Publication of WO2015124113A1 publication Critical patent/WO2015124113A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/322,3-Dihydro derivatives, e.g. flavanones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06Benzopyran radicals
    • C07H17/065Benzo[b]pyrans
    • C07H17/07Benzo[b]pyran-4-ones

Definitions

  • the present invention relates to a method for semi-synthesizing luteolin, luteolin, luteolin rutin, hesperetin-7-O-glucoside semi-synthetic luteolin, and hesperetin semi-synthetic luteolin by hesperidin Its field belongs to chemistry and medicine.
  • Hesperidin and luteolin resources comparison Hesperidin is widely found in Rutaceae plants, such as orange peel, citrus is also the world's largest fruit, China has abundant citrus resources, and the use of citrus in China is limited. In the use of citrus fruit, the peel has not received enough attention, and citrus peel as a by-product of processing accounts for 30% to 50%. Only a small portion was recovered for use as tangerine peel and extracted hesperidin, but most of it was discarded, causing great waste and environmental pollution.
  • pericarpin should not be less than 5.0%
  • hesperidin content of the tangerine peel should not be less than 3.5%
  • the hesperidin is rich in source
  • the extraction process is simple
  • the price is low.
  • 90% hesperidin per kilogram is about 180 yuan.
  • Hesperidin can be used as a raw material to semi-synthesize dioxin, geranin, luteolin, luteolin-7-O-glucoside, and methyl hesperidin.
  • luteolin and its glycosides are 3,4,5,7-tetrahydroxyflavonoids and their glycoside derivatives, which are mainly found in plants such as chrysanthemum, honeysuckle, travertine, goat's milk and sclerotium. High anti-inflammatory, anti-oxidant, anti-tumor and other biological activities.
  • luteolin is low in the natural world and expensive, and 98% luteolin is 2,000 yuan per kilogram.
  • Hesperidin semi-synthetic luteolin existing method luteolin can be prepared by hesperidin semi-synthesis, there are usually three methods reported in the literature or patents: (1) hesperidin hydrolyzed hesperetin, hesperetin Dehydrogenation produces geranyl lignin and geranyl demethylation to prepare luteolin.
  • the reaction formula is shown in (I) ([1] Li Yushan.
  • Hesperidin semi-synthetic luteolin deficiency The above three methods of hesperidin semi-synthetic luteolin are three steps, each step uses more organic reagents, some reagents are not recycled, on the one hand, the cost is increased. On the other hand, it pollutes the environment; each step requires purification, drying, etc., on the one hand, the production cycle is long, on the other hand, the sample has a certain loss during the treatment process, which reduces the yield of the product, and the separation is troublesome.
  • the demethylation of geranyl lignin is described as follows: it is slightly soluble in glacial acetic acid, demethylated with glacial acetic acid-HBr, and glacial acetic acid-HBr is also difficult to recover. Therefore, the demethylation method is usually pyridine-aluminum trichloride, but since pyridine and aluminum trichloride form a salt, it is difficult to form a homogeneous solvent, so the amount thereof is large, since pyridine can form a salt with aluminum trichloride and phenol, and is recovered. The rate is limited and the environment is polluted.
  • luteolin is luteolin-7-O-glucoside, which is less in plants, such as the 2010 edition of the Chinese Pharmacopoeia honeysuckle regulation containing luteolin (C 21 H 20 O 11 ) Not less than 0.05%, the chrysanthemum contains no less than 0.080%, and the content of chlorogenic acid in the honeysuckle is higher than that of honeysuckle, but does not contain luteolin. Because of the trace amount of luteolin, the price is 1/ of honeysuckle. 2-1/3, but its application range is far less than honeysuckle, the reason is that the mountain silver flower does not contain luteolin, which makes people more respect for honeysuckle.
  • Luteolin is produced by the reaction of luteolin with 2,3,4,6-tetra-O-acetyl-aD-bromopyranose.
  • the luteolin was synthesized from hesperidin, and the luteolin was prepared from hesperidin by 35%.
  • the luteolin was prepared by luteolin.
  • the total yield of the two steps was 16.8%. Based on hesperidin, the total yield of the five steps was 5.88% ([2] Criminal Power, Sun Zhizhong, Han Wenhui, Han Xiaoling. Semi-synthesis of luteolin and glucoside [J]. Chinese Journal of Pharmaceutical Industry, 1994, 25(11): 484-487.
  • hesperidin, dipyridin, and hesperetin-7-O-glucoside selectively remove methyl groups from the molecule, which is entirely a new challenge. If this method can be achieved, hesperidin, The steps of dimethoate, hesperetin-7-O-glucoside, hesperetin semi-synthetic luteolin, luteolin, luteolin rutin are greatly reduced, the cost is greatly reduced, and industrial application value is obtained.
  • Oxygen free radical damage and flavonoid protection The cell membrane has its loose chemical structure, is extremely elastic and flexible, and its electrons are easily lost. Therefore, once the cell membrane is attacked by free radicals, its electrons are taken away, its function is lost, various inflammations are caused, and it is further deteriorated, resulting in various diseases such as cardiovascular diseases and tumors.
  • Some endogenous enzymes such as superoxide dismutase (SOD), catalase, glutathione peroxidase, and vitamin C, vitamin E, carotene and other compounds, have the ability to scavenge free radicals . In addition to the above substances, in order to reduce the risk of free radicals, it is also necessary to find and discover exogenous free radical scavengers.
  • flavonoids have many physiological activities and pharmacological effects such as anti-oxidation, anti-cancer, anti-AIDS, anti-bacterial, anti-allergic, anti-inflammatory, etc., and have no toxic and side effects, which are of great significance for the prevention and treatment of human tumors, aging and cardiovascular diseases.
  • the flavonoid molecule contains multiple phenolic hydroxyl groups, which are easily metabolized by the intestinal flora or the liver enzyme system, and the metabolites also have corresponding phenolic hydroxyl groups.
  • the free radical scavenging effect of phenolic hydroxyl groups contained in flavonoids and metabolites may be the basis of many of their effects.
  • ortho-diphenol has an important effect on the action of flavonoids and other compounds, which may be due to its strong antioxidant activity.
  • Antioxidant activity of flavonoids H 2 O 2 clearance rate is commonly used for antioxidant activity, and erioconsin-7-rutinoside and luteolin-7-rutinoside have strong anti-H 2 O 2 activity.
  • Hesperidin has weak anti-H 2 O 2 activity, and naringin, diosmin, and quercetin have almost no H 2 O 2 activity ([5]Zbigniew Sroka*, Izabela Fecka, and Wojciech Cisowski. Antiradical and Anti-H 2 O 2 Properties of Polyphenolic Compounds from an Aqueous Peppermint Extract. Z. Naturforsch, 2005, 60 (826): 832.).
  • the content of chlorogenic acid is higher than that of honeysuckle, and the yield per mu is 2-3 times that of honeysuckle.
  • the price is 1/2-1/3 of honeysuckle, but its application range is far less than that of honeysuckle.
  • the mountain silver flower does not contain limonium. Glycoside, which makes people more respect for honeysuckle. If the extract of arborvitae is added to luteolin, the chlorogenic acid and luteolin are the same as the active ingredients of honeysuckle, and the effect of antibacterial and other effects is not much different, then the silver stalk can be used instead of luteolin instead of honeysuckle. Since the yield of the mountain silver flower is much higher than that of the honeysuckle, it can save a lot of cultivated land.
  • flavonoids contain two benzene rings in the molecule. Due to the planarity of the benzene ring, the molecules and molecules are easily overlapped, making them insoluble in water, such as orange. Derinoside, naringin, rutin, baicalin, etc. When the A ring has a polyhydroxy compound and the B ring has no hydroxyl group, the molecules are more likely to undergo self-phase rearrangement to form crystals, and their solubility in water is small.
  • baicalin contains only o-diphenolic hydroxyl group in ring A
  • B ring is not, insoluble in water, and insoluble in solvents such as methanol, ethanol, acetone, etc.
  • breviscapine has one ortho-diphenolic hydroxyl group in addition to ring A, and one ring in B ring.
  • Luteolin is very soluble in water
  • luteolin-7-O-glucoside is slightly soluble in water
  • luteolin-7-O-rutinoside soluble in water
  • soluble in hot water indicating increased glycosylation It is beneficial to improve water solubility.
  • the object of the present invention is to provide semi-synthetic luteolin, luteolin, luteolin rutinoside from hesperidin, hesperetin, hesperetin-7-O-glucoside, which has fewer steps, lower cost and high yield. , environmentally friendly industrial preparation methods.
  • Pyridines, trivalent aluminum ion compounds, low boiling alcohols, hesperidin, and iodine are mixed and dehydrogenated at room temperature -110 ° C to form a homogenous liquid, and the dehydrogenation of the starting product is completely followed by PC/TLC/HPLC. Then, it is sealed and sealed at 80 ° C - 180 ° C for 2-80 h. The demethylation product is traced by PC/TLC/HPLC. The distilled product is dissolved by heating with alcohol, phosphoric acid is added, and the precipitate is precipitated (Dioxing).
  • Acid-7-rutinoside acid solution passed Macroporous adsorption resin adsorption, water elution and impurity removal, ethanol elution, recovery of ethanol, can obtain luteolin-7-rutinoside; luteolin-7-rutinoside acid water can be obtained by acid hydrolysis, luteolin And a mixture of luteolin, which can be obtained by silica gel column chromatography to obtain luteolin and luteolin monomer; the acid water of luteolin-7-rutino is completely hydrolyzed in alcohol to obtain luteolin.
  • the process produces HI and HI and pyridine salts, in which I ions are highly polarizable and easy to attack C+ ions in OCH 3 ; on the other hand, Al 3+ is complexed with ortho-dioxy to facilitate OCO 3 de- arming Base, two aspects of synergy, demethylation is easier and more selective.
  • the two reactions of dehydrodemethylation can be carried out directly in the same vessel without separation.
  • the pyridines referred to in the present invention mainly refer to pyridine, 2-methylpyridine, 3-methylpyridine, 4-methylpyridine, 4-methylpyridine, 5-methylpyridine, 6-methylpyridine, 2 , 6-lutidine, 3,5-lutidine, 2,4,6-trimethylpyridine.
  • the trivalent aluminum ion compound in the present invention mainly refers to aluminum trichloride, aluminum tribromide, aluminum triiodide, aluminum methoxide, aluminum ethoxide, aluminum propoxide, etc., and preferably anhydrous aluminum trichloride, wherein Aluminum halide: orange peel
  • the molar ratio of glycoside (or hesperetin or hesperetin-7-O-glucoside) is from 3:1 to 1:3, preferably 1:1.
  • the low-boiling alcohol in the present invention means methanol, ethanol, propanol or isopropanol, of which methanol is preferred, and the amount of methanol used is not more than the volume of the pyridine.
  • Hesperidin (CAS: 520-26-3), hesperetin (CAS: 520-33-2), hesperetin-7-O-glucoside (CAS:31712-49-9) in the present invention the structure is as (A)) as the dehydrogenation and de-starting reactant, wherein the hesperidin (or hesperetin or hesperetin-7-O-glucoside): pyridine is in a molar ratio of 1:5-1 : 10, preferably 1:6-1:7.
  • the iodine, the amount thereof and the hesperetin (or hesperidin or hesperetin-7-O-glucoside) molar ratio are preferably 1:1.
  • the distillation temperature is from 80 ° C to 180 ° C, preferably from 90 ° C to 150 ° C.
  • the closed state means that outside air cannot enter the reactor during the distillation, but the air in the reactor can be discharged, and the alcohol And pyridine vapors can be condensed and discharged.
  • the luteolin (CAS: 491-70-3), luteolin (CAS: 5373-11-5), and luteolin-7-O-rutinoside (CAS: 20633-84-5,
  • the structure is as in (B)).
  • the dehydrogenation and deprotection are combined into one step, wherein since it is a solution type, the yield of dehydrogenation to produce geranin and the derivative is 100%, and the dislocation is directly separated without separation, and the geranyl-7-O - Demethylation of rutinoside (Diomin) to prepare luteolin-7-O-rutinoside, yield 60%-75%, luteolin-7-O-
  • the rutinoside has high water solubility, and there is a certain loss in the enrichment and purification process, and the yield will decrease;
  • the geranyl-7-O-glucoside demethylation yield is between 50% and 65%, and its water solubility It is less soluble, can be precipitated and precipitated, and has high yield; lignan is demethylated by double distillation to prepare luteolin.
  • the yield is above 95%. Luteolin is insoluble in water and is easy to be purified.
  • hesperetin and its glycoside derivatives are complexed with aluminum, the dehydro-demethylated products are easily soluble in the alcohol solution of pyridine, so the amount of pyridine is particularly small.
  • the method and the existing patents and reports of hesperidin Semi-synthetic luteolin has significant improvements. Dehydro-demethylation of hesperidin or hesperetin-7-O-glucoside to prepare luteolin glycoside is a breakthrough invention. Semi-synthetic route of luteolin, luteolin, luteolin and rutin, with mild reaction conditions and easy operation; low reagent dosage and low cost; few steps, high dehydrogenation and demethylation yield, easy industrial production .
  • luteolin-7-O-rutinoside is preferred to dehydro-demethylation in one step of hesperidin; the production of luteolin preferentially dehydrogenates in one step of hesperetin-7-O-glucoside Demethylation; luteolin is recommended for dehydrogenation in a one-step process, followed by several times of closed distillation demethylation.
  • Dioxin has been directly demethylated, but in the alcohol and pyridine, the dissolution rate with AlCl 3 is very slow, and it is difficult to form a uniform solution, and the demethylation effect is not good; likewise, hesperidin and In the alcohol and pyridine, the demethylation yield of the complex with AlCl 3 is very low, and it is mainly subjected to a long-term distillation and is mainly a de-sugar product.
  • the luteolin-7-O-rutinoside is highly polar, and it is difficult to be adsorbed by the macroporous adsorption resin D101 type, AB-8, polyamide or the like in the acid aqueous solution of pyridine.
  • Hesperidin is prepared by hesperidin. If the method of patent No. 201310692053.X is used, the preparation of hesperidin is extremely low. Hesperidin-7-O-glucoside is prepared by hesperidin. If the method is patent No. 201310692053.X or 201410051283.2, hesperetin-7-O-glucoside is inexpensive to prepare.
  • the invention discloses a method for one-step dehydrogenation and demethylation of hesperetin, hesperetin-7-O-glucoside and hesperidin, and those skilled in the art can learn from the contents of this paper to screen the types of pyridines and alcohols. , optimizing the demethylation temperature and the amount of alcohol in the closed distillation.
  • luteolin-7-O-rutinoside is prepared by dehydro-demethylation of hesperidin, and luteolin and luteolin, hesperetin-7-O-glucoside are prepared by hydrolysis.
  • Dehydro-demethylation to prepare luteolin hesperidin dehydro-demethylation to prepare luteolin, alcohol as methanol, pyridine, pyridine, trivalent aluminum ion compound with anhydrous AlCl 3 as an example,
  • the reagent AR indicates analytical purity.
  • anhydrous aluminum trichloride (AR) 3.5g in a 250ml iodine flask quickly add 15ml of pyridine (AR), shake well, add 8ml of methanol (AR), 2min, add 92% hesperidin 16.5g Stir for 5min, add iodine (AR) 6.8g, add 7ml of methanol (AR), stir for 3min, end the iodine bottle with a condenser or air condensing tube, and seal at 80 °C (to prevent absorption of moisture in the air) every 1h After stirring for 1 time, a homogeneous solution was formed after 2 hours, and the closed reaction was continued for 6 hours (dehydrogenation was completed).
  • AR aluminum trichloride
  • Example 3 Preparation of hesperidin Luteolin-7-O-rutinoside was hydrolyzed by acid alcohol solution, and luteolin was quickly weighed into anhydrous aluminum chloride (AR) 3.5 g in 250 ml iodine flask, and quickly added.
  • AR anhydrous aluminum chloride
  • anhydrous aluminum trichloride (AR) 3.5g in a 250ml iodine volumetric flask quickly add 15ml of pyridine (AR), shake well, add methanol (AR) 8ml, 2min, add 92% hesperidin 12g, Stir for 5min, add iodine (AR) 6.8g, add 7ml of methanol (AR), stir for 3min, end the iodine bottle with a condenser or air condensing tube, seal at 80 °C (prevent the absorption of moisture in the air), stir every 1h One time, a homogeneous solution was formed after 2 hours, and the closed reaction was continued for 6 hours (complete dehydrogenation).
  • AR aluminum trichloride
  • anhydrous aluminum trichloride (AR) 3.5g in a 250ml iodine volumetric flask quickly add 15ml of pyridine (AR), shake well, add methanol (AR) 8ml, 2min, add 98% hesperetin 8.5g Stir for 5min, add iodine (AR) 6.8g, add 7ml of methanol (AR), stir for 3min, end the iodine bottle with a condenser or air condensing tube, and seal at 80 °C (to prevent absorption of moisture in the air) every 1h After stirring for 1 time, a homogeneous solution was formed after 2 hours, and the closed reaction was continued for 6 hours (dehydrogenation was completed).
  • AR aluminum trichloride

Abstract

Provided is a semi-synthesis method for luteolin, galuteolin and luteolin rutinoside. In the method, two steps of dehydrogenation and demethylation are combined into one step, and reaction conditions of dehydrogenation and demethylation are mild and easy to control; few reagents are used so that the method is green and environmentally friendly; and the demethylation yield is high, and industrial production is easy to realize.

Description

木犀草素、木犀草苷、木犀草素芸香糖苷半合成的方法Method for semi-synthesis of luteolin, luteolin and luteolin rutinoside 技术领域Technical field
本发明涉及由橙皮苷半合成木犀草素、木犀草苷、木犀草素芸香苷,橙皮素-7-O-葡萄糖苷半合成木犀草苷,和橙皮素半合成木犀草素的方法,其领域属于化学和医药。The present invention relates to a method for semi-synthesizing luteolin, luteolin, luteolin rutin, hesperetin-7-O-glucoside semi-synthetic luteolin, and hesperetin semi-synthetic luteolin by hesperidin Its field belongs to chemistry and medicine.
背景技术Background technique
橙皮苷及木犀草素资源对比:橙皮苷广泛存在于芸香科植物中,如橘皮等,柑橘也是世界最大的水果,我国有丰富的柑桔资源,在国内对柑桔的利用仅局限在对柑桔果实的利用,对果皮还没引起足够的重视,柑橘皮渣作为加工的副产品占30%~50%。仅有少部分被回收作为陈皮和提取橙皮苷使用,但大部分被丢弃,造成极大的浪费和环境污染。2010版中国药典规定青皮含橙皮苷不得低于5.0%,陈皮含橙皮苷含量不得低于3.5%,橙皮苷来源丰富,提取工艺简单,价格低廉,每公斤90%橙皮苷约为180元。以橙皮苷作为原料,可以半合成地奥明、香叶木素、木犀草素、木犀草素-7-O-葡萄糖苷、甲基橙皮苷。其中木犀草素及其糖苷类是3,4,5,7-四羟基黄酮类化合物及其糖苷衍生物,主要存在于菊花、金银花、络石藤、羊乳、透骨草等植物中,具有很高的抗炎、抗氧化、抗肿瘤等生物活性。然木犀草素在天然界中含量较低,价格昂贵,98%木犀草素每公斤为2000元。Hesperidin and luteolin resources comparison: Hesperidin is widely found in Rutaceae plants, such as orange peel, citrus is also the world's largest fruit, China has abundant citrus resources, and the use of citrus in China is limited. In the use of citrus fruit, the peel has not received enough attention, and citrus peel as a by-product of processing accounts for 30% to 50%. Only a small portion was recovered for use as tangerine peel and extracted hesperidin, but most of it was discarded, causing great waste and environmental pollution. The 2010 edition of the Chinese Pharmacopoeia stipulates that the pericarpin should not be less than 5.0%, the hesperidin content of the tangerine peel should not be less than 3.5%, the hesperidin is rich in source, the extraction process is simple, and the price is low. 90% hesperidin per kilogram is about 180 yuan. Hesperidin can be used as a raw material to semi-synthesize dioxin, geranin, luteolin, luteolin-7-O-glucoside, and methyl hesperidin. Among them, luteolin and its glycosides are 3,4,5,7-tetrahydroxyflavonoids and their glycoside derivatives, which are mainly found in plants such as chrysanthemum, honeysuckle, travertine, goat's milk and sclerotium. High anti-inflammatory, anti-oxidant, anti-tumor and other biological activities. However, luteolin is low in the natural world and expensive, and 98% luteolin is 2,000 yuan per kilogram.
橙皮苷半合成木犀草素现有方法:可通过橙皮苷半合成制备木犀草素,现有文献或专利报道的方法通常有三种:(1)橙皮苷水解橙皮素,橙皮素脱氢生成香叶木素,香叶木素脱甲基制备木犀草素,其反应式见(I)([1]李玉山.一种橙皮苷制备木犀草素的新技术[P].2013,CN,201310004892.8);(2)橙皮苷脱氢生产地奥司明,地奥司明水解生成香叶木素,香叶木素脱甲基制备木犀草素,3步总收率为35%,其反应见(II)([2]刑有权,孙志忠,韩文辉,韩晓玲.木犀草素及葡萄糖苷的半合成[J].中国医药工业杂志,1994,25(11):484-487);(3)橙皮苷水解橙皮素,橙皮素脱甲基生成圣草酚,圣草酚脱氢生成木犀草素,三步总收率为45.9%,其反应见(III)([3]孙志忠,郝文辉,段树红,等.木犀草素的 半合成.中国现代应用药学杂志,1999,16(1):30-31)。Hesperidin semi-synthetic luteolin existing method: luteolin can be prepared by hesperidin semi-synthesis, there are usually three methods reported in the literature or patents: (1) hesperidin hydrolyzed hesperetin, hesperetin Dehydrogenation produces geranyl lignin and geranyl demethylation to prepare luteolin. The reaction formula is shown in (I) ([1] Li Yushan. A new technology for the preparation of luteolin from hesperidin [P].2013, CN, 201310004892.8); (2) dehydrogenation of hesperidin to produce odisamine, diosmin hydrolyzed to produce geranyl lignin, and geranyl lignin demethylated to prepare luteolin, the total yield of 3 steps is 35%, See (II) ([2] Criminal Power, Sun Zhizhong, Han Wenhui, Han Xiaoling. Semi-synthesis of luteolin and glucoside[J]. Chinese Journal of Pharmaceutical Industry, 1994, 25(11): 484-487); (3) Hesperidin hydrolyzed hesperetin, demethylation of hesperetin to eriophthol, dehydrogenation of ergophenol to luteolin, the total yield of three steps is 45.9%, and the reaction is seen in (III) ([3 Sun Zhizhong, Hao Wenhui, Duan Shuhong, et al. Semi-synthesis. Chinese Journal of Modern Applied Pharmacy, 1999, 16(1): 30-31).
Figure PCTCN2015073238-appb-000001
Figure PCTCN2015073238-appb-000001
橙皮苷半合成木犀草素缺陷:上述橙皮苷半合成木犀草素的三种方法,均为三步,每一步均用到较多有机试剂,有些试剂未加回收,一方面增加了成本,另一方面污染环境;每一步产品均需要纯化、干燥等处理,一方面生产周期长,另一方面处理过程中导致样品有一定损失,降低了产品的收率,分离较为麻烦。如以香叶木素脱甲基为例说明:微溶于冰醋酸中,用冰醋酸-HBr脱甲基,同样存在冰醋酸-HBr难以回收。故其脱甲基方法常用吡啶-三氯化铝,但由于吡啶和三氯化铝形成盐,难以形成均相溶剂,故其用量大,由于吡啶能和三氯化铝及酚形成盐,回收率有限,对环境污染较大。 Hesperidin semi-synthetic luteolin deficiency: The above three methods of hesperidin semi-synthetic luteolin are three steps, each step uses more organic reagents, some reagents are not recycled, on the one hand, the cost is increased. On the other hand, it pollutes the environment; each step requires purification, drying, etc., on the one hand, the production cycle is long, on the other hand, the sample has a certain loss during the treatment process, which reduces the yield of the product, and the separation is troublesome. For example, the demethylation of geranyl lignin is described as follows: it is slightly soluble in glacial acetic acid, demethylated with glacial acetic acid-HBr, and glacial acetic acid-HBr is also difficult to recover. Therefore, the demethylation method is usually pyridine-aluminum trichloride, but since pyridine and aluminum trichloride form a salt, it is difficult to form a homogeneous solvent, so the amount thereof is large, since pyridine can form a salt with aluminum trichloride and phenol, and is recovered. The rate is limited and the environment is polluted.
木犀草苷半合成方法及缺陷:木犀草苷是木犀草素-7-O-葡萄糖苷,其在植物中含量少,如2010版中国药典金银花规定含木犀草苷(C21H20O11)不低于0.05%、菊花中含木犀草苷不得少于0.080%,而山银花绿原酸含量高于金银花,但不含木犀草苷,因微量木犀草苷原故,价格是金银花的1/2-1/3,但其应用范围远不及金银花,究其原因是山银花不含木犀草苷,致使人们更推崇金银花。木犀草素苷,则由木犀草素和2,3,4,6-四-O-乙酰-a-D-溴吡喃葡萄糖反应生成。以橙皮苷合成木犀草苷,橙皮苷制备木犀草素经3步总收率为35%,木犀草素制备木犀草苷,2步总收率为16.8%。以橙皮苷计,5步合计总收率为5.88%([2]刑有权,孙志忠,韩文辉,韩晓玲.木犀草素及葡萄糖苷的半合成[J].中国医药工业杂志,1994,25(11):484-487。很明显,现有橙皮苷半合成木犀草苷,步骤多,产率过低,并且2,3,4,6-四-O-乙酰-a-D-溴吡喃葡萄糖价格较贵,导致工业化成本较高。Semi-synthesis method and defect of luteolin: luteolin is luteolin-7-O-glucoside, which is less in plants, such as the 2010 edition of the Chinese Pharmacopoeia honeysuckle regulation containing luteolin (C 21 H 20 O 11 ) Not less than 0.05%, the chrysanthemum contains no less than 0.080%, and the content of chlorogenic acid in the honeysuckle is higher than that of honeysuckle, but does not contain luteolin. Because of the trace amount of luteolin, the price is 1/ of honeysuckle. 2-1/3, but its application range is far less than honeysuckle, the reason is that the mountain silver flower does not contain luteolin, which makes people more respect for honeysuckle. Luteolin is produced by the reaction of luteolin with 2,3,4,6-tetra-O-acetyl-aD-bromopyranose. The luteolin was synthesized from hesperidin, and the luteolin was prepared from hesperidin by 35%. The luteolin was prepared by luteolin. The total yield of the two steps was 16.8%. Based on hesperidin, the total yield of the five steps was 5.88% ([2] Criminal Power, Sun Zhizhong, Han Wenhui, Han Xiaoling. Semi-synthesis of luteolin and glucoside [J]. Chinese Journal of Pharmaceutical Industry, 1994, 25(11): 484-487. It is obvious that the existing hesperidin semi-synthetic luteolin has many steps, the yield is too low, and 2,3,4,6-tetra-O-acetyl-aD-bromopyrrol The price of glucone is relatively expensive, resulting in higher industrialization costs.
Figure PCTCN2015073238-appb-000002
Figure PCTCN2015073238-appb-000002
糖苷类化合物脱甲基及缺陷:在葛根素的全合成中,其脱甲基使用了昂贵的三甲基碘硅烷及较为昂贵的试剂乙腈为溶剂([4]张培成.黄酮化学[M].化学工业出版社,2009,357),进行脱甲基,导致产品成本高昂,与天然植物葛根中提取,不具备合成优势。葛根素Demethylation and Defects of Glycoside Compounds: In the total synthesis of puerarin, demethylation uses expensive trimethyliodosilane and the more expensive reagent acetonitrile as solvent ([4] Zhang Peicheng. Flavonoid Chemistry [M]. Chemical Industry Press, 2009, 357), demethylation, resulting in high product costs, extracted from the natural plant Pueraria, does not have a synthetic advantage. Puerarin
Figure PCTCN2015073238-appb-000003
Figure PCTCN2015073238-appb-000003
Figure PCTCN2015073238-appb-000004
Figure PCTCN2015073238-appb-000004
为碳苷,在脱甲基过程中,不会发生水解,其稳定性远远高于氧苷。然而氧苷遇酸易水解、遇热易脱水,其稳定性远差于酚甲醚,用现有的脱甲基方法对氧苷甲醚脱甲基,得到的产物是先脱糖、后脱甲基,最后脱糖和脱甲基得到苷元,由于在高温下,糖环甚至可能脱水,与黄酮母核进行反应,其产物较为复杂,难以得到先脱甲基而保留糖的苷。故氧苷优先脱酚甲基而保留糖环尚未见报道。因此,橙皮苷、地奥明、橙皮素-7-O-葡萄糖苷选择性脱去分子中甲基,完全是一种新的挑战,如果这一种方法能够实现,由橙皮苷、地奥明、橙皮素-7-O-葡萄糖苷、橙皮素半合成木犀草素、木犀草苷、木犀草素芸香苷的步骤大为减少,成本大为降低,具有工业应用价值。As a carbon glycoside, hydrolysis does not occur during the demethylation process, and its stability is much higher than that of oxyglucoside. However, oxyglucosides are easily hydrolyzed by acid, easily dehydrated by heat, and their stability is far worse than that of phenol methyl ether. Demethylation of oxomethyl ether is carried out by the existing demethylation method, and the obtained product is first de-sugarized and then desorbed. Methyl group, the last de-saccharification and demethylation to obtain aglycon, because the sugar ring may even dehydrate at high temperature, and react with the flavonoid nucleus, the product is more complicated, and it is difficult to obtain the glycoside which is demethylated first and retains the sugar. Therefore, it has not been reported that oxoside preferentially dephenolate methyl and retains sugar ring. Therefore, hesperidin, dipyridin, and hesperetin-7-O-glucoside selectively remove methyl groups from the molecule, which is entirely a new challenge. If this method can be achieved, hesperidin, The steps of dimethoate, hesperetin-7-O-glucoside, hesperetin semi-synthetic luteolin, luteolin, luteolin rutin are greatly reduced, the cost is greatly reduced, and industrial application value is obtained.
氧自由基危害及黄酮保护作用。细胞膜具有它松散的化学结构,极富有弹性和柔韧性,它的电子很容易丢失。因此,细胞膜一旦受自由基攻击,其电子被夺走,其功能就丧失,引发各种炎症,进一步恶化,产生各种各样的疾病,如心血管系统疾病、肿瘤等。一些内源性的酶,如超氧化物歧化酶(SOD)、过氧化氢酶、谷胱甘肽过氧化酶,和维生素C、维生素E、胡箩卜素等化合物,具有清除自由基的能力。除了上述物质,要降低自由基的危害,还需要寻找和发掘外源性的自由基清除剂,利用这些物质优先于自由基结合,阻断外界的自由基对人体的攻击,使人体免受伤害。大量研究证明黄酮具有抗氧化、抗癌、抗艾滋病、抗菌、抗过敏、抗炎等多种生理活性及药理作用,且无毒副作用,对人类的肿瘤、衰老、心血管疾病的防治具有重要意义。黄酮类化合物分子含有多个酚羟基,易于被肠道菌群或肝脏酶系统所代谢,代谢产物亦有相应的酚羟基。黄酮及代谢产物所含酚羟基的自由基清除作用,可能是其诸多作用的基础。Oxygen free radical damage and flavonoid protection. The cell membrane has its loose chemical structure, is extremely elastic and flexible, and its electrons are easily lost. Therefore, once the cell membrane is attacked by free radicals, its electrons are taken away, its function is lost, various inflammations are caused, and it is further deteriorated, resulting in various diseases such as cardiovascular diseases and tumors. Some endogenous enzymes, such as superoxide dismutase (SOD), catalase, glutathione peroxidase, and vitamin C, vitamin E, carotene and other compounds, have the ability to scavenge free radicals . In addition to the above substances, in order to reduce the risk of free radicals, it is also necessary to find and discover exogenous free radical scavengers. These substances are used in preference to free radical binding to block the attack of free radicals on the human body and protect the human body from harm. . A large number of studies have proved that flavonoids have many physiological activities and pharmacological effects such as anti-oxidation, anti-cancer, anti-AIDS, anti-bacterial, anti-allergic, anti-inflammatory, etc., and have no toxic and side effects, which are of great significance for the prevention and treatment of human tumors, aging and cardiovascular diseases. . The flavonoid molecule contains multiple phenolic hydroxyl groups, which are easily metabolized by the intestinal flora or the liver enzyme system, and the metabolites also have corresponding phenolic hydroxyl groups. The free radical scavenging effect of phenolic hydroxyl groups contained in flavonoids and metabolites may be the basis of many of their effects.
邻二酚抗氧化及药理作用显著:A、B两个苯环通过三碳相连构成黄酮类化合物,当A环具有5-OH、7-OH二羟基,其中7-OH常常形成糖苷键,5-OH与4C=O形成分子内氢键,则故A环抗氧化性较弱。当B环含有邻二酚羟基,其抗氧化性强,药理作用也相对好,如芦丁、木犀草素及糖苷、圣草酚糖苷。再 如中药其它具有邻二酚羟基的化合物,也具有较好的药理活性,如原儿茶醛、丹参素、绿原酸等化合物。上述说明邻二酚对黄酮等化合物的作用具有重要的影响,可能系其具有较强的抗氧化性所致。黄酮类化合物抗氧化活性研究,抗氧化活性强弱常用H2O2清除率表述,圣草酚-7-芸香糖苷、木犀草素-7-芸香糖苷具有较强的抗H2O2活性,橙皮苷的抗H2O2活性较弱,柚皮苷、地奥司明、野漆树苷几乎无抗H2O2活性([5]Zbigniew Sroka*,Izabela Fecka,and Wojciech Cisowski.Antiradical and Anti-H2O2 Properties of Polyphenolic Compoundsfrom an Aqueous Peppermint Extract.Z.Naturforsch,2005,60(826):832.)。O-diphenol has significant antioxidant and pharmacological effects: A and B benzene rings are linked by three carbons to form flavonoids. When ring A has 5-OH and 7-OH dihydroxy groups, 7-OH often forms glycosidic bonds. -OH forms an intramolecular hydrogen bond with 4C=O, so the A ring has weak oxidation resistance. When the B ring contains ortho-diphenolic hydroxyl groups, it has strong antioxidant activity and relatively good pharmacological effects, such as rutin, luteolin and glycosides, and eriocitrin. For example, other compounds with ortho-diphenolic hydroxyl groups in traditional Chinese medicines also have good pharmacological activities, such as protocatechuic aldehyde, Danshensu, chlorogenic acid and the like. The above description of ortho-diphenol has an important effect on the action of flavonoids and other compounds, which may be due to its strong antioxidant activity. Antioxidant activity of flavonoids, H 2 O 2 clearance rate is commonly used for antioxidant activity, and erioconsin-7-rutinoside and luteolin-7-rutinoside have strong anti-H 2 O 2 activity. Hesperidin has weak anti-H 2 O 2 activity, and naringin, diosmin, and quercetin have almost no H 2 O 2 activity ([5]Zbigniew Sroka*, Izabela Fecka, and Wojciech Cisowski. Antiradical and Anti-H 2 O 2 Properties of Polyphenolic Compounds from an Aqueous Peppermint Extract. Z. Naturforsch, 2005, 60 (826): 832.).
抗生素滥用危害,呼唤中药代替品:自从1928年弗莱明发现青霉素以来,抗生素挽救了无数人的生命。目前抗生素在医疗及养殖业上的使用越来越广泛,在很多地区甚至处于滥用的状况。但抗生素在消炎杀菌的同时,对机体的免疫系统也会产生广泛的影响,例如头痛、恶心、呕吐、便秘等。因此寻找安全、低毒副作用,有效的替代药物的工作是必要的。医学界许多专家正在寻找中药替代西药抗菌素。金银花是我国名贵中药,具有清热解毒、疏散风热的功效,其提取物广泛应用药品如双黄连制剂、银翘解毒片、金银花露。同时,饮料和日化行业需求也在激增,已开发出的产品有:金银花饮料(加多宝、王老吉),金银花啤酒、金银花牙膏等。山银花也具有清热解毒、疏散风热的功效,在2000年版及以前药典,与金银花为同一种药物,到2005版药典,因微量木犀草苷原故,始分为两种药物。然绿原酸含量高于金银花,亩产量也是金银花的2-3倍,价格是金银花的1/2-1/3,但其应用范围远不及金银花,究其原因是山银花不含木犀草苷,致使人们更推崇金银花。如果山银花提取物加入木犀草苷,使其绿原酸和木犀草苷与金银花有效成分一致,在抗菌等功效相差不大,则完全可利用山银花勾兑木犀草苷代替金银花。由于山银花产量较金银花产量高得多,则可以节约大量耕地。Antibiotic abuse hazard, calling for Chinese medicine substitutes: Since Fleming discovered penicillin in 1928, antibiotics have saved countless lives. At present, antibiotics are increasingly used in medical and aquaculture, and are even in abuse in many areas. However, antibiotics can have a wide-ranging effect on the body's immune system, such as headache, nausea, vomiting, constipation, etc., while reducing inflammation and sterilization. Therefore, it is necessary to find safe, low-toxic side effects and effective alternative medicine. Many experts in the medical field are looking for Chinese medicine to replace Western medicine antibiotics. Honeysuckle is a valuable traditional Chinese medicine with the functions of clearing away heat and detoxifying and evacuating wind and heat. Its extracts are widely used in medicines such as Shuanghuanglian preparation, Yinqiao Jiedu Tablet and Honeysuckle Flower Dew. At the same time, the demand for beverages and daily chemical industry is also exploding. The products that have been developed include: honeysuckle drinks (Jiduobao, Wang Laoji), honeysuckle beer, honeysuckle toothpaste and so on. The mountain silver flower also has the effect of clearing away heat and detoxifying and evacuating wind and heat. In the 2000 edition and the previous pharmacopoeia, it was the same medicine as honeysuckle. In the 2005 edition of the pharmacopoeia, it was divided into two kinds of drugs because of the trace of luteolin. However, the content of chlorogenic acid is higher than that of honeysuckle, and the yield per mu is 2-3 times that of honeysuckle. The price is 1/2-1/3 of honeysuckle, but its application range is far less than that of honeysuckle. The reason is that the mountain silver flower does not contain limonium. Glycoside, which makes people more respect for honeysuckle. If the extract of arborvitae is added to luteolin, the chlorogenic acid and luteolin are the same as the active ingredients of honeysuckle, and the effect of antibacterial and other effects is not much different, then the silver stalk can be used instead of luteolin instead of honeysuckle. Since the yield of the mountain silver flower is much higher than that of the honeysuckle, it can save a lot of cultivated land.
糖类及多酚羟基对黄酮类有增溶作用:黄酮类化合物由于分子中含有两个苯环,由于苯环的平面性,分子与分子之间易于重叠排列,致使难溶于水,如橙皮苷、柚皮苷、芦丁、黄芩苷等。当A环具有多羟基化合物,而B环没有羟基,分子之间更易进行自相重排,形成结晶,其在水中溶解度很小。如黄芩苷仅在A环含邻二酚羟基,B环没有,不溶于水、难溶于甲醇、乙醇、丙酮等溶剂,而灯盏花素除了A环有邻二酚羟基、B环也有1个羟基,溶于甲醇,乙醇、热 水。野漆树苷难溶于水,而木犀草素-7-O-新橙皮糖苷,可溶于水,二者区别在于前者比后者在B环上少一个3’-OH,说明增加酚羟基,提高极性,利于增加其水溶性。木犀草素极微溶于水,木犀草素-7-O-葡萄糖苷微溶于水,木犀草素-7-O-芸香糖苷,可溶于水,易溶于热水,说明增加糖基,有利于提高水溶性。Carbohydrates and polyphenolic hydroxyl groups have solubilization effect on flavonoids: flavonoids contain two benzene rings in the molecule. Due to the planarity of the benzene ring, the molecules and molecules are easily overlapped, making them insoluble in water, such as orange. Derinoside, naringin, rutin, baicalin, etc. When the A ring has a polyhydroxy compound and the B ring has no hydroxyl group, the molecules are more likely to undergo self-phase rearrangement to form crystals, and their solubility in water is small. For example, baicalin contains only o-diphenolic hydroxyl group in ring A, B ring is not, insoluble in water, and insoluble in solvents such as methanol, ethanol, acetone, etc., and breviscapine has one ortho-diphenolic hydroxyl group in addition to ring A, and one ring in B ring. Hydroxyl, soluble in methanol, ethanol, heat water. Wild laccase is insoluble in water, while luteolin-7-O-neo-hesperidin is soluble in water. The difference between the two is that the former has one less 3'-OH than the latter on the B ring, indicating an increase in phenolic hydroxyl groups. Increase polarity and help increase its water solubility. Luteolin is very soluble in water, luteolin-7-O-glucoside is slightly soluble in water, luteolin-7-O-rutinoside, soluble in water, soluble in hot water, indicating increased glycosylation It is beneficial to improve water solubility.
综上所述,利用来源丰富,制备工艺简单,价格低廉橙皮苷及其衍生物,如橙皮素-7-O-葡萄糖苷、橙皮素半合成木犀草素芸香苷、木犀草苷、木犀草素,利用后三者具有优异抗菌、抗肿瘤、抗氧化作用,低毒副作用,用于医药、食品、化妆品领域,造福人类,已经迫切重要。In summary, the use of abundant sources, simple preparation process, low price of hesperidin and its derivatives, such as hesperetin-7-O-glucoside, hesperetin semi-synthetic luteolin rutin, luteolin, Luteolin, the latter three have excellent antibacterial, anti-tumor, anti-oxidation effects, low toxic and side effects, used in the fields of medicine, food, cosmetics, for the benefit of mankind, has been urgently important.
发明内容Summary of the invention
本发明目的:提供由橙皮苷、橙皮素、橙皮素-7-O-葡萄糖苷半合成木犀草素、木犀草苷、木犀草素芸香糖苷,具有步骤少,成本低,产率高,绿色环保的工业化制备方法。The object of the present invention is to provide semi-synthetic luteolin, luteolin, luteolin rutinoside from hesperidin, hesperetin, hesperetin-7-O-glucoside, which has fewer steps, lower cost and high yield. , environmentally friendly industrial preparation methods.
解决办法:将橙皮素、橙皮苷、橙皮素-7-O-葡萄糖苷脱氢和脱甲基两步反应合并到一步法中反应。Solution: Combine the two-step reaction of hesperetin, hesperidin, hesperetin-7-O-glucoside dehydrogenation and demethylation into a one-step reaction.
本发明技术特征:Technical features of the invention:
吡啶类、三价铝离子化合物、低沸点的醇、橙皮素、碘混合,在室温-110℃反应脱氢,形成均一液,PC/TLC/HPLC跟踪起始产物脱氢完全。然后在80℃-180℃密闭蒸馏2-80h,PC/TLC/HPLC跟踪检查脱甲基产物(当一次密闭蒸馏脱甲基不完全时,可将蒸馏液倒入反应器中,经加热搅拌溶解,再进行密闭蒸馏,可提高脱甲基产物的收率),将蒸馏产物加醇加热溶解,加入磷酸,析出木犀草素;Pyridines, trivalent aluminum ion compounds, low-boiling alcohols, hesperetin, and iodine are mixed and dehydrogenated at room temperature to 110 ° C to form a homogenous liquid, and the dehydrogenation of the starting product is completely followed by PC/TLC/HPLC. Then, it is sealed at 80 °C-180 °C for 2-80 h, and the demethylation product is checked by PC/TLC/HPLC. (When the decarboxylation is incomplete in a closed distillation, the distillate can be poured into the reactor and dissolved by heating and stirring. , and then performing closed distillation to increase the yield of the demethylated product), the distillation product is heated and dissolved by adding alcohol, and phosphoric acid is added to precipitate luteolin;
吡啶类、三价铝离子化合物、低沸点的醇、橙皮素-7-O-葡萄糖苷、碘混合,在室温-110℃反应脱氢,形成均一液,PC/TLC/HPLC跟踪起始产物脱氢完全。然后在80℃-180℃密闭蒸馏2-80h,PC/TLC/HPLC跟踪检查脱甲基产物,将蒸馏产物加醇加热溶解,加入磷酸,析出木犀草苷和香叶木素-7-O-葡萄糖苷,经层析分离可得木犀草苷和香叶木素-7-O-葡萄糖苷;Pyridines, trivalent aluminum ion compounds, low boiling alcohols, hesperetin-7-O-glucoside, iodine mixed, dehydrogenation at room temperature -110 ° C to form a homogeneous solution, PC / TLC / HPLC tracking starting products Dehydrogenation is complete. Then, it is sealed and sealed at 80 ° C - 180 ° C for 2-80 h. The demethylation product is traced by PC/TLC/HPLC. The distilled product is dissolved by heating with alcohol, and phosphoric acid is added to precipitate luteolin and geranyl-7-O-glucoside. , luteolin and geranyl-7-O-glucoside can be obtained by chromatography;
吡啶类、三价铝离子化合物、低沸点的醇、橙皮苷、碘混合,在室温--110℃反应脱氢,形成均一液,PC/TLC/HPLC跟踪起始产物脱氢完全。然后在80℃-180℃密闭蒸馏2-80h,PC/TLC/HPLC跟踪检查脱甲基产物,将蒸馏产物加醇加热溶解,加入磷酸,析出沉淀(地奥明),滤过,得木犀草素-7-芸香苷的酸水液:通过 大孔吸附树脂吸附,水洗脱除杂,乙醇洗脱,回收乙醇,可得木犀草素-7-芸香糖苷;木犀草素-7-芸香苷的酸水液通过酸水解,可得木犀草素及木犀草苷混合物,经硅胶柱层析分离可得木犀草苷及木犀草素单体;木犀草素-7-芸香苷的酸水液在醇中完全水解,可得木犀草素。Pyridines, trivalent aluminum ion compounds, low boiling alcohols, hesperidin, and iodine are mixed and dehydrogenated at room temperature -110 ° C to form a homogenous liquid, and the dehydrogenation of the starting product is completely followed by PC/TLC/HPLC. Then, it is sealed and sealed at 80 ° C - 180 ° C for 2-80 h. The demethylation product is traced by PC/TLC/HPLC. The distilled product is dissolved by heating with alcohol, phosphoric acid is added, and the precipitate is precipitated (Dioxing). Acid-7-rutinoside acid solution: passed Macroporous adsorption resin adsorption, water elution and impurity removal, ethanol elution, recovery of ethanol, can obtain luteolin-7-rutinoside; luteolin-7-rutinoside acid water can be obtained by acid hydrolysis, luteolin And a mixture of luteolin, which can be obtained by silica gel column chromatography to obtain luteolin and luteolin monomer; the acid water of luteolin-7-rutino is completely hydrolyzed in alcohol to obtain luteolin.
本发明原理:The principle of the invention:
橙皮素或其糖苷衍生物脱氢、脱甲制备木犀草素或其糖苷类,其机理相同,分子中的4-C=O,5-OH与Al3+络合,易溶于吡啶类和醇液中,通过加热脱氢,脱氢产物亦与Al3+络合,仍以溶液形式存在,通过密闭蒸馏醇液和多余的吡啶类,以甲醇和吡啶为例说明:一方面利用反应过程产生的HI和HI与吡啶类盐,其中I离子可极化性强,易于进攻OCH3中的C+离子;另一方面,Al3+与邻二氧络合,有利于OCH3脱去甲基,两个方面的协同作用,脱甲基较为容易,选择性较高。脱氢脱甲基两个反应可在同一容器中,不经分离,直接完成。Dehydrogenation and demethylation of hesperetin or its glycoside derivatives to prepare luteolin or its glycosides, the mechanism is the same, 4-C=O, 5-OH in the molecule is complexed with Al 3+ , and is easily soluble in pyridine In the alcohol liquid, dehydrogenation by heating, the dehydrogenation product is also complexed with Al 3+ , still exists in the form of a solution, and the methanol and pyridine are exemplified by the closed distillation of the alcohol liquid and the excess pyridine. The process produces HI and HI and pyridine salts, in which I ions are highly polarizable and easy to attack C+ ions in OCH 3 ; on the other hand, Al 3+ is complexed with ortho-dioxy to facilitate OCO 3 de- arming Base, two aspects of synergy, demethylation is easier and more selective. The two reactions of dehydrodemethylation can be carried out directly in the same vessel without separation.
Figure PCTCN2015073238-appb-000005
Figure PCTCN2015073238-appb-000005
在本发明所说的吡啶类,主要指吡啶、2-甲基吡啶、3-甲基吡啶、4-甲基吡啶、4-甲基吡啶、5-甲基吡啶、6-甲基吡啶、2,6-二甲基吡啶、3,5-二甲基吡啶、2,4,6-三甲基吡啶。The pyridines referred to in the present invention mainly refer to pyridine, 2-methylpyridine, 3-methylpyridine, 4-methylpyridine, 4-methylpyridine, 5-methylpyridine, 6-methylpyridine, 2 , 6-lutidine, 3,5-lutidine, 2,4,6-trimethylpyridine.
在本发明所说的三价铝离子化合物,主要指三氯化铝、三溴化铝、三碘化铝,甲醇铝、乙醇铝、丙醇铝等,优先选择无水三氯化铝,其中卤化铝:橙皮 苷(或橙皮素或橙皮素-7-O-葡萄糖苷)的摩尔比在3:1-1:3,优先为1:1。The trivalent aluminum ion compound in the present invention mainly refers to aluminum trichloride, aluminum tribromide, aluminum triiodide, aluminum methoxide, aluminum ethoxide, aluminum propoxide, etc., and preferably anhydrous aluminum trichloride, wherein Aluminum halide: orange peel The molar ratio of glycoside (or hesperetin or hesperetin-7-O-glucoside) is from 3:1 to 1:3, preferably 1:1.
在本发明所说的低沸点醇,指甲醇、乙醇、丙醇、异丙醇,其中优选甲醇,其甲醇用量以体积计,不超过吡啶类用量体积。The low-boiling alcohol in the present invention means methanol, ethanol, propanol or isopropanol, of which methanol is preferred, and the amount of methanol used is not more than the volume of the pyridine.
在本发明所说的橙皮苷(CAS:520-26-3)、橙皮素(CAS:520-33-2)、橙皮素-7-O-葡萄糖苷(CAS:31712-49-9,结构如(A))作为脱氢脱甲起始反应物,其中橙皮苷(或橙皮素或橙皮素-7-O-葡萄糖苷):吡啶类的摩尔比在1:5-1:10,优选为1:6-1:7。Hesperidin (CAS: 520-26-3), hesperetin (CAS: 520-33-2), hesperetin-7-O-glucoside (CAS:31712-49-9) in the present invention , the structure is as (A)) as the dehydrogenation and de-starting reactant, wherein the hesperidin (or hesperetin or hesperetin-7-O-glucoside): pyridine is in a molar ratio of 1:5-1 : 10, preferably 1:6-1:7.
Figure PCTCN2015073238-appb-000006
Figure PCTCN2015073238-appb-000006
在本发明所说的碘、其用量与橙皮素(或橙皮苷、或橙皮素-7-O-葡萄糖苷)摩尔比优选1:1。In the present invention, the iodine, the amount thereof and the hesperetin (or hesperidin or hesperetin-7-O-glucoside) molar ratio are preferably 1:1.
在本发明所说的密闭蒸馏,指蒸馏温度在80℃-180℃,优选90℃-150℃,密闭指在蒸馏过程中,外界空气不能进入反应器中,但反应器中空气可排出,醇及吡啶类蒸汽可被冷凝排出。In the closed distillation according to the present invention, the distillation temperature is from 80 ° C to 180 ° C, preferably from 90 ° C to 150 ° C. The closed state means that outside air cannot enter the reactor during the distillation, but the air in the reactor can be discharged, and the alcohol And pyridine vapors can be condensed and discharged.
本发明所说的木犀草素(CAS:491-70-3)、木犀草苷(CAS:5373-11-5)、木犀草素-7-O-芸香糖苷(CAS:20633-84-5,结构如(B))。The luteolin (CAS: 491-70-3), luteolin (CAS: 5373-11-5), and luteolin-7-O-rutinoside (CAS: 20633-84-5, The structure is as in (B)).
Figure PCTCN2015073238-appb-000007
Figure PCTCN2015073238-appb-000007
本发明中将脱氢脱甲合并到一步,其中由于是溶液型,故脱氢生成香叶木素及衍生物的产率为100%,不经分离,直接脱甲,由香叶木素-7-O-芸香糖苷(地奥明)脱甲基制备木犀草素-7-O-芸香糖苷,产率在60%-75%,木犀草素-7-O- 芸香糖苷水溶性较高,在富集纯化过程中有一定损耗,收率会有所下降;香叶木素-7-O-葡萄糖苷脱甲基产率在50%-65%之间,其水溶性较小,可沉淀析出,收率高;香叶木素经二次蒸馏脱甲基制备木犀草素,产率在95%以上,木犀草素不溶于水,很容易纯化处理。In the present invention, the dehydrogenation and deprotection are combined into one step, wherein since it is a solution type, the yield of dehydrogenation to produce geranin and the derivative is 100%, and the dislocation is directly separated without separation, and the geranyl-7-O - Demethylation of rutinoside (Diomin) to prepare luteolin-7-O-rutinoside, yield 60%-75%, luteolin-7-O- The rutinoside has high water solubility, and there is a certain loss in the enrichment and purification process, and the yield will decrease; the geranyl-7-O-glucoside demethylation yield is between 50% and 65%, and its water solubility It is less soluble, can be precipitated and precipitated, and has high yield; lignan is demethylated by double distillation to prepare luteolin. The yield is above 95%. Luteolin is insoluble in water and is easy to be purified.
由于橙皮素及其糖苷衍生物与铝络合,其脱氢脱甲基产物均易溶于吡啶的醇液中,故吡啶用量特别少,该方法与现有专利及文献报道的橙皮苷半合成木犀草素,具有重大改进。橙皮苷或橙皮素-7-O-葡萄糖苷脱氢脱甲基制备木犀草素糖苷,为突破性的发明。木犀草素、木犀草苷、木犀草素芸香苷半合成的路线,具有反应条件温和、易于操作;试剂用量少,成本低廉;步骤少,脱氢脱甲基产率较高,易于工业化生产。其中,木犀草素-7-O-芸香糖苷的生产优先推荐橙皮苷一步法中脱氢脱甲基;木犀草苷的生产优先推荐橙皮素-7-O-葡萄糖苷一步法中脱氢脱甲基;木犀草素优推荐一步法中脱氢之后,多次密闭蒸馏脱甲基。Since hesperetin and its glycoside derivatives are complexed with aluminum, the dehydro-demethylated products are easily soluble in the alcohol solution of pyridine, so the amount of pyridine is particularly small. The method and the existing patents and reports of hesperidin Semi-synthetic luteolin has significant improvements. Dehydro-demethylation of hesperidin or hesperetin-7-O-glucoside to prepare luteolin glycoside is a breakthrough invention. Semi-synthetic route of luteolin, luteolin, luteolin and rutin, with mild reaction conditions and easy operation; low reagent dosage and low cost; few steps, high dehydrogenation and demethylation yield, easy industrial production . Among them, the production of luteolin-7-O-rutinoside is preferred to dehydro-demethylation in one step of hesperidin; the production of luteolin preferentially dehydrogenates in one step of hesperetin-7-O-glucoside Demethylation; luteolin is recommended for dehydrogenation in a one-step process, followed by several times of closed distillation demethylation.
本发明曾用地奥明直接脱甲基,但地奥明在醇和吡啶中,与AlCl3络合溶解速度很慢,形成均匀溶液难度较高,脱甲基效果不好;同样,橙皮苷与在醇和吡啶中,与AlCl3络合其脱甲基产率很低,经密闭长时间蒸馏,主要为脱糖产物。木犀草素-7-O-芸香糖苷极性较大,其在吡啶的酸水液中,难以被大孔吸附树脂D101型、AB-8、聚酰胺等吸附。经过多次筛选,T-02、T-01、HPD-D、DM130、HPD400、HPD500对木犀草素芸香糖苷有一定的吸附能力。橙皮苷制备橙皮素,若采用专利号为201310692053.X的方法,橙皮素制备成本极其低廉。橙皮苷制备橙皮素-7-O-葡萄糖苷,若采用专利号为201310692053.X或201410051283.2的方法,橙皮素-7-O-葡萄糖苷制备成本低廉。In the present invention, Dioxin has been directly demethylated, but in the alcohol and pyridine, the dissolution rate with AlCl 3 is very slow, and it is difficult to form a uniform solution, and the demethylation effect is not good; likewise, hesperidin and In the alcohol and pyridine, the demethylation yield of the complex with AlCl 3 is very low, and it is mainly subjected to a long-term distillation and is mainly a de-sugar product. The luteolin-7-O-rutinoside is highly polar, and it is difficult to be adsorbed by the macroporous adsorption resin D101 type, AB-8, polyamide or the like in the acid aqueous solution of pyridine. After repeated screening, T-02, T-01, HPD-D, DM130, HPD400, and HPD500 have certain adsorption capacity for luteolin rutinoside. Hesperidin is prepared by hesperidin. If the method of patent No. 201310692053.X is used, the preparation of hesperidin is extremely low. Hesperidin-7-O-glucoside is prepared by hesperidin. If the method is patent No. 201310692053.X or 201410051283.2, hesperetin-7-O-glucoside is inexpensive to prepare.
在进行密闭蒸馏时,蒸馏温度过高,则会导致糖苷脱水。同时,吡啶类或醇类速度过快,溶液变固体速度加快,脱甲基能力会随时间延长,脱甲基能力逐渐下降,效果亦不好。当在低温下蒸馏醇类或吡啶类,然后再高温,则会出现膨胀现象(底部固体逐渐膨胀,体积膨胀原体积数倍乃至数十倍,有可能溢出瓶外)。密闭蒸馏时间过长,分子中若有糖,导致脱糖产物增加。When the closed distillation is carried out, if the distillation temperature is too high, the glycoside is dehydrated. At the same time, the pyridine or alcohol is too fast, the solution becomes solid faster, the demethylation ability will prolong with time, the demethylation ability gradually decreases, and the effect is not good. When the alcohol or pyridine is distilled at a low temperature and then at a high temperature, expansion phenomenon occurs (the bottom solid gradually expands, and the volume expands the original volume several times or even several tens of times, possibly overflowing the bottle). The closed distillation time is too long, and if there is sugar in the molecule, the de-sugar product increases.
以下结合实施例,进一步说明本发明The present invention will be further described below in conjunction with the embodiments.
本发明公开了橙皮素、橙皮素-7-O-葡萄糖苷、橙皮苷一步法脱氢脱甲基的方法,本领域技术人员可以借鉴本文内容,对吡啶类、醇的种类进行筛选,对密闭蒸馏 脱甲基温度、醇的用量进行优化。特别需要指出橙皮素及其糖苷类脱氢脱甲基制备木犀草素及其糖苷类的方法中,是通过与铝离子络合一步法完成,都将被视为本发明,相关人员明显不能在脱离本发明的内容、精神和范围对本文所述的方法、原理进行适当改动或变更与组合,来实现和应用本发明技术;由于涉及的醇类、吡啶类、三价铝离子化合物较多,用于制备木犀草素及其糖苷,不能一一列举。但为了进一步理解本发明,以橙皮苷脱氢脱甲基制备木犀草素-7-O-芸香糖苷、再经水解制备木犀草苷和木犀草素、橙皮素-7-O-葡萄糖苷脱氢脱甲基制备木犀草苷、橙皮素脱氢脱甲基制备木犀草素,醇类以甲醇为例,吡啶类以吡啶、三价铝离子化合物以无水AlCl3为例进行说明,其中试剂AR表示分析纯。The invention discloses a method for one-step dehydrogenation and demethylation of hesperetin, hesperetin-7-O-glucoside and hesperidin, and those skilled in the art can learn from the contents of this paper to screen the types of pyridines and alcohols. , optimizing the demethylation temperature and the amount of alcohol in the closed distillation. In particular, it is necessary to point out that the process of dehydro- and demethylation of hesperetin and its glycosides to prepare luteolin and its glycosides is accomplished by a one-step method of complexation with aluminum ions, which will be regarded as the present invention, and the relevant personnel obviously cannot The methods and principles described herein are appropriately modified or altered and combined to achieve and apply the techniques of the present invention without departing from the spirit, scope, and scope of the present invention; since the alcohol, pyridine, and trivalent aluminum ion compounds involved are more For the preparation of luteolin and its glycosides, can not be enumerated. However, in order to further understand the present invention, luteolin-7-O-rutinoside is prepared by dehydro-demethylation of hesperidin, and luteolin and luteolin, hesperetin-7-O-glucoside are prepared by hydrolysis. Dehydro-demethylation to prepare luteolin, hesperidin dehydro-demethylation to prepare luteolin, alcohol as methanol, pyridine, pyridine, trivalent aluminum ion compound with anhydrous AlCl 3 as an example, Wherein the reagent AR indicates analytical purity.
实施例1 橙皮苷制备木犀草素-7-O-芸香糖苷Example 1 Preparation of luteolin-7-O-rutinoside by hesperidin
迅速称取无水三氯化铝(AR)3.5g于250ml碘量瓶中,迅速加入吡啶(AR)15ml,摇匀,加入甲醇(AR)8ml,2min后,加入92%橙皮苷16.5g,搅拌2min,加入碘(AR)6.8g,加入甲醇(AR)7ml,搅拌2min,碘量瓶上端接冷凝管或空气冷凝管,于80℃密闭反应(防止吸收空气中水分),每隔1h搅拌1次,2h后形成均匀溶液,继续密闭反应6h(完成脱氢)。在空气浴中,114℃密闭蒸馏15h(脱甲基反应,瓶内由溶液型变为固体,热时较软,冷却时很坚硬),放置80℃,加入10ml乙醇及10ml丙三醇,并80℃保温2h,固体转变为溶液,加入保险粉1.0g,搅拌5min后,倒入200ml 5%磷酸水液中,快速搅拌,并在50℃水浴中密闭放置1h,滤过(不溶物为地奥明,烘干后约为4.8g)得酸水液,通过350g大孔吸附树脂,水洗涤除去吡啶、HI、磷酸、丙三醇、乙醇、AlCl3,以乙醇洗脱,回收乙醇得木犀草素-7-O-芸香糖苷10.8g,经HPLC测定纯度为90.8%(以98%木犀草苷作为内标物)。13CNMR(DMSO-d6,100 MHz):d 182.08(s,C-4),164.74(s,C-2),163.01(s,C-7),161.37(s,C-5),157.08(s,C-9),150.12(s,C-4′),145.92(s,C-3′),121.47(s,C-1′),119.40(d,C-6′),116.32(d,C-5′),113.73(d,C-2′),105.53(s,C-10),103.28(d,C-3),100.65(d,Gly-1),99.99(d,C-6),94.95(d,C-8),76.42(t,Gly-5),75.67,(s,Gly-3),73.25(d,Gly-2),69.70(d,Gly-4),66.15(t,Gly-6).99.66(Rha-1),70.28(Rha-2),70.88(Rha-3),72.20(Rha-4),68.50(Rha-5)17.99.50(Rha-6);TOF MS ES+m/z617.1464[M+Na]+,m/z449.1066[M-146+H]+,m/z287.0550[M-146-162+H]+。TOF MS ES-m/z 593.1527[M-H]-, m/z285.0414[M-146-162-H]-,(calc.for.C27H30O15)(结构鉴定用样品系90.8%的木犀草素-7-O-芸香糖苷经硅胶柱分离)。Quickly weigh anhydrous aluminum trichloride (AR) 3.5g in a 250ml iodine flask, quickly add 15ml of pyridine (AR), shake well, add 8ml of methanol (AR), 2min, add 92% hesperidin 16.5g Stir for 2min, add iodine (AR) 6.8g, add 7ml of methanol (AR), stir for 2min, end the iodine bottle with a condenser or air condensing tube, and seal at 80 °C (prevent the absorption of moisture in the air) every 1h After stirring for 1 time, a homogeneous solution was formed after 2 hours, and the closed reaction was continued for 6 hours (dehydrogenation was completed). In an air bath, sealed at 114 ° C for 15 h (demethylation reaction, the solution changed from solution to solid, soft when hot, very hard when cooled), placed at 80 ° C, added 10 ml of ethanol and 10 ml of glycerol, and After incubating at 80 °C for 2 h, the solid was converted into a solution, and 1.0 g of the insurance powder was added. After stirring for 5 min, it was poured into 200 ml of 5% phosphoric acid water solution, rapidly stirred, and sealed in a water bath at 50 ° C for 1 h, filtered (insoluble matter for the ground) Omin, about 4.8g after drying, get acid water, pass 350g macroporous adsorption resin, wash with water to remove pyridine, HI, phosphoric acid, glycerol, ethanol, AlCl 3 , elute with ethanol, recover ethanol to get rhododendron The oxacin-7-O-rutinoside was 10.8 g, and the purity was determined by HPLC to be 90.8% (with 98% luteolin as an internal standard). 13 C NMR (DMSO-d6, 100 MHz): d 182.08 (s, C-4), 164.74 (s, C-2), 163.01 (s, C-7), 161.37 (s, C-5), 157.08 ( s, C-9), 150.12 (s, C-4'), 145.92 (s, C-3'), 121.47 (s, C-1'), 119.40 (d, C-6'), 116.32 (d , C-5'), 113.73 (d, C-2'), 105.53 (s, C-10), 103.28 (d, C-3), 100.65 (d, Gly-1), 99.99 (d, C- 6), 94.95 (d, C-8), 76.42 (t, Gly-5), 75.67, (s, Gly-3), 73.25 (d, Gly-2), 69.70 (d, Gly-4), 66.15 (t, Gly-6).99.66 (Rha-1), 70.28 (Rha-2), 70.88 (Rha-3), 72.20 (Rha-4), 68.50 (Rha-5) 17.99.50 (Rha-6) ; TOF MS ES+m/z 617.1464 [M+Na] + , m/z 449.1066 [M-146+H] + , m/z 287.0550 [M-146-162+H] + . TOF MS ES-m/z 593.1527[MH] - , m/z285.0414[M-146-162-H] - , (calc.for.C 27 H 30 O 15 ) (90.8% of the sample for structural identification) Luteolin-7-O-rutinoside was separated on a silica gel column).
实施例2 橙皮苷制备木犀草素-7-O-芸香糖苷经酸水解,得木犀草苷和木犀草素Example 2 Preparation of hesperidin to produce luteolin-7-O-rutinoside by acid hydrolysis to obtain luteolin and luteolin
迅速称取无水三氯化铝(AR)3.5g于250ml碘量瓶中,迅速加入吡啶(AR)15ml,摇匀,加入甲醇(AR)8ml,2min后,加入92%橙皮苷16.5g,搅拌5min,加入碘(AR)6.8g,加入甲醇(AR)7ml,搅拌3min,碘量瓶上端接冷凝管或空气冷凝管,于80℃密闭反应(防止吸收空气中水分),每隔1h搅拌1次,2h后形成均匀溶液,继续密闭反应6h(完成脱氢)。在空气浴中,112℃密闭蒸馏17h(脱甲基反应,瓶内由溶液型变为固体,热时较软,冷却时很坚硬),放置80℃,加入20ml乙醇,并80℃保温3h,固体转变为溶液,加入保险粉1.0g,搅拌5min后,倒入100ml 5%磷酸水液中,快速搅拌,并在50℃水浴中密闭放置1h,滤过(不溶物为地奥明,烘干后约为4.7g)得酸水液,加入盐酸20ml,于80℃密闭水解3h,析出沉淀,滤过,得木犀草素和木犀草苷混合物,经硅胶柱层析分离,得木犀草苷3.0g,木犀草素3.2g。Quickly weigh anhydrous aluminum trichloride (AR) 3.5g in a 250ml iodine flask, quickly add 15ml of pyridine (AR), shake well, add 8ml of methanol (AR), 2min, add 92% hesperidin 16.5g Stir for 5min, add iodine (AR) 6.8g, add 7ml of methanol (AR), stir for 3min, end the iodine bottle with a condenser or air condensing tube, and seal at 80 °C (to prevent absorption of moisture in the air) every 1h After stirring for 1 time, a homogeneous solution was formed after 2 hours, and the closed reaction was continued for 6 hours (dehydrogenation was completed). In an air bath, sealed at 112 ° C for 17 h (demethylation reaction, the solution changed from solution to solid, soft when hot, very hard when cooled), placed at 80 ° C, added 20 ml of ethanol, and kept at 80 ° C for 3 h, The solid is converted into a solution, and 1.0 g of the powder is added. After stirring for 5 minutes, it is poured into 100 ml of 5% phosphoric acid water solution, rapidly stirred, and sealed in a water bath at 50 ° C for 1 h, filtered (insoluble matter is deomin, dried) After about 4.7g), the acid water solution was added, 20ml of hydrochloric acid was added, and the mixture was hydrolyzed at 80 ° C for 3 hours to precipitate a precipitate. The mixture was filtered to obtain a mixture of luteolin and luteolin, which was separated by silica gel column chromatography to obtain luteolin 3.0. g, luteolin 3.2g.
实施例3 橙皮苷制备木犀草素-7-O-芸香糖苷经酸醇液水解,得木犀草素迅速称取无水三氯化铝(AR)3.5g于250ml碘量瓶中,迅速加入吡啶(AR)15ml,摇匀,加入甲醇(AR)8ml,2min后,加入92%橙皮苷16.5g,搅拌5min,加入碘(AR)6.8g,加入甲醇(AR)7ml,搅拌3min,碘量瓶上端接冷凝管或空气冷凝管,于80℃密闭反应(防止吸收空气中水分),每隔1h搅拌1次,2h后形成均匀溶液,继续密闭反应6h(完成脱氢)。在空气浴中,116℃密闭蒸馏15h(脱甲基反应,瓶内由溶液型变为固体,热时较软,冷却时很坚硬),放置80℃,加入20ml乙醇,并80℃保温3h,固体转变为溶液,加入保险粉1.0g,搅拌5min后,倒入100ml 5%磷酸水液中,快速搅拌,并在50℃水浴中密闭放置1h,滤过(不溶物为地奥明,烘干后约为5.0g)得酸水液,加入乙醇100ml,加入盐酸30ml,于80℃密闭水解5h,析出沉淀,滤过,得木犀草素5.6g。UVλmax nm in MeOH:346,258;+NaOMe 407,267;+AlCl3422,320sh,265;+AlCl3/HCl 390,375,273。Example 3 Preparation of hesperidin Luteolin-7-O-rutinoside was hydrolyzed by acid alcohol solution, and luteolin was quickly weighed into anhydrous aluminum chloride (AR) 3.5 g in 250 ml iodine flask, and quickly added. 15ml of pyridine (AR), shake well, add 8ml of methanol (AR), after 2min, add 16.5g of 92% hesperidin, stir for 5min, add iodine (AR) 6.8g, add methanol (AR) 7ml, stir for 3min, iodine The measuring bottle is terminated with a condensing tube or an air condensing tube, and the reaction is sealed at 80 ° C (to prevent absorption of moisture in the air), and stirred once every 1 hour. After 2 hours, a uniform solution is formed, and the sealing reaction is continued for 6 hours (complete dehydrogenation). In an air bath, sealed at 116 ° C for 15 h (demethylation reaction, the solution changed from solution to solid, soft when hot, very hard when cooled), placed at 80 ° C, added 20 ml of ethanol, and kept at 80 ° C for 3 h, The solid is converted into a solution, and 1.0 g of the powder is added. After stirring for 5 minutes, it is poured into 100 ml of 5% phosphoric acid water solution, rapidly stirred, and sealed in a water bath at 50 ° C for 1 h, filtered (insoluble matter is deomin, dried) After about 5.0 g), an aqueous acid solution was obtained, 100 ml of ethanol was added, 30 ml of hydrochloric acid was added, and the mixture was hydrolyzed at 80 ° C for 5 hours to precipitate a precipitate, which was filtered to obtain 5.6 g of luteolin. UV λ max nm in MeOH: 346, 258; + NaOMe 407, 267; + AlCl 3 422, 320 sh, 265; + AlCl 3 / HCl 390, 375, 273.
实施例4 橙皮素-7-O-葡萄糖苷制备木犀草苷 Example 4 Preparation of luteolin by hesperetin-7-O-glucoside
迅速称取无水三氯化铝(AR)3.5g于250ml碘量瓶中,迅速加入吡啶(AR)15ml,摇匀,加入甲醇(AR)8ml,2min后,加入92%橙皮苷12g,搅拌5min,加入碘(AR)6.8g,加入甲醇(AR)7ml,搅拌3min,碘量瓶上端接冷凝管或空气冷凝管,于80℃密闭反应(防止吸收空气中水分),每隔1h搅拌1次,2h后形成均匀溶液,继续密闭反应6h(完成脱氢)。在空气浴中,113℃密闭蒸馏15h(脱甲基反应,瓶内由溶液型变为固体,热时较软,冷却时很坚硬),放置80℃,加入20ml乙醇,并80℃保温3h,固体转变为溶液,加入保险粉1.0g,搅拌5min后,倒入100ml 5%磷酸水液中,快速搅拌,并在50℃水浴中密闭放置1h,滤过,得木犀草苷和香叶木素-7-O-葡萄糖苷混合物,经硅胶柱层析分离,得木犀草苷5.7g,经HPLC测定纯度为94%。1HNMR(DMSO-d6,400MHz):δ13.01(1H,s,5-OH),10.05(1H,s,4′-OH),9.45(1H,s,3′-OH),7.45(1H,dd,J=8.4/2.2,H-6'),7.44(1H,d,J=2.2,H-2'),6.80(1H,d,J=8.4,H-5'),6.77(1H,dd,J=1.8,H-8),6.77(1H,s,H-3),6.46(1H,dd,J=1.8,H-6),5.11(1H,d,J=7.3,H-1″),4.06(1H,d,J=9.5,H-6″),3.88(1H,dd,J=3.5/1.6 Hz,H-2″'),3.69,(1H,dd,J=9.5/3.3 Hz,H-3″'),3.18–3.68(7H,m,H-2″,3″,4″,5″,6″a,4″',5″'),1.10(3H,d,J=6.2 Hz,H-6″');13CNMR(DMSO-d6,100 MHz):d 181.97(s,C-4),164.50(s,C-2),162.97(s,C-7),161.18(s,C-5),156.99(s,C-9),149.97(s,C-4′),145.83(s,C-3′),121.42(s,C-1′),119.23(d,C-6′),116.01(d,C-5′),113.60(d,C-2′),105.37(s,C-10),103.31(d,C-3),99.85(d,Gly-1),99.57(d,C-6),94.74(d,C-8),77.18(t,Gly-5),76.42,(s,Gly-3),73.14(d,Gly-2),69.53(d,Gly-4),60.63(t,Gly-6);TOF MS ES+m/z471.0909[M+Na]+,m/z449.1145[M+H]+,m/z287.0571[M-162+H]+。TOF MSES-m/z 447.0922[M-H]-,m/z285.0401[M-162-H]-,(calc.for.C21H20O11)。Quickly weigh anhydrous aluminum trichloride (AR) 3.5g in a 250ml iodine volumetric flask, quickly add 15ml of pyridine (AR), shake well, add methanol (AR) 8ml, 2min, add 92% hesperidin 12g, Stir for 5min, add iodine (AR) 6.8g, add 7ml of methanol (AR), stir for 3min, end the iodine bottle with a condenser or air condensing tube, seal at 80 °C (prevent the absorption of moisture in the air), stir every 1h One time, a homogeneous solution was formed after 2 hours, and the closed reaction was continued for 6 hours (complete dehydrogenation). In an air bath, sealed at 113 ° C for 15 h (demethylation reaction, the solution changed from solution to solid, soft when hot, very hard when cooled), placed at 80 ° C, added 20 ml of ethanol, and kept at 80 ° C for 3 h, The solid was converted into a solution, and 1.0 g of the powder was added. After stirring for 5 minutes, it was poured into 100 ml of 5% phosphoric acid aqueous solution, rapidly stirred, and sealed in a water bath at 50 ° C for 1 h, and filtered to obtain luteolin and geranin-7. The mixture of -O-glucoside was separated by silica gel column chromatography to obtain 5.7 g of luteolin, and the purity was 94% by HPLC. 1 H NMR (DMSO-d6, 400 MHz): δ 13.01 (1H, s, 5-OH), 10.05 (1H, s, 4'-OH), 9.45 (1H, s, 3'-OH), 7.45 (1H) , dd, J=8.4/2.2, H-6'), 7.44 (1H, d, J=2.2, H-2'), 6.80 (1H, d, J=8.4, H-5'), 6.77 (1H , dd, J = 1.8, H-8), 6.77 (1H, s, H-3), 6.46 (1H, dd, J = 1.8, H-6), 5.11 (1H, d, J = 7.3, H- 1′′), 4.06 (1H, d, J=9.5, H-6′′), 3.88 (1H, dd, J=3.5/1.6 Hz, H-2′′′), 3.69, (1H, dd, J=9.5 /3.3 Hz, H-3"'), 3.18 - 3.68 (7H, m, H-2", 3", 4", 5", 6" a, 4", 5"'), 1.10 (3H, d, J = 6.2 Hz, H-6"'); 13 CNMR (DMSO-d6, 100 MHz): d 181.97 (s, C-4), 164.50 (s, C-2), 162.97 (s, C- 7), 161.18 (s, C-5), 156.99 (s, C-9), 149.97 (s, C-4'), 145.83 (s, C-3'), 121.42 (s, C-1') , 119.23 (d, C-6'), 116.01 (d, C-5'), 113.60 (d, C-2'), 105.37 (s, C-10), 103.31 (d, C-3), 99.85 (d, Gly-1), 99.57 (d, C-6), 94.74 (d, C-8), 77.18 (t, Gly-5), 76.42, (s, Gly-3), 73.14 (d, Gly -2), 69.53 (d, Gly-4), 60.63 (t, Gly-6); TOF MS ES+m/z 471.0909 [M+Na] + , m/z 449.1145 [M+H] + , m/z 287.0571 [M-162+H] + . TOF MSES-m/z 447.0922 [MH] - , m/z 285.0401 [M-162-H] - , (calc. for. C 21 H 20 O 11 ).
实施例5 橙皮素制备木犀草素Example 5 Preparation of luteolin by hesperetin
迅速称取无水三氯化铝(AR)3.5g于250ml碘量瓶中,迅速加入吡啶(AR)15ml,摇匀,加入甲醇(AR)8ml,2min后,加入98%橙皮素8.5g,搅拌5min,加入碘(AR)6.8g,加入甲醇(AR)7ml,搅拌3min,碘量瓶上端接冷凝管或空气冷凝管,于80℃密闭反应(防止吸收空气中水分),每隔1h搅拌1次,2h后形成均匀溶液,继续密闭反应6h(完成脱氢)。在空气浴中,113℃密闭蒸馏15h(脱甲基反应,瓶内由溶液型变为固体,热时较软,冷却时很坚硬),放置80℃。 将蒸馏液重新倒入碘量瓶中,并80℃保温3h,固体转变为溶液,再与空气浴中,116℃密闭蒸馏15h(二次脱甲基),放置80℃,加入乙醇100ml,加热溶解,快速加入磷酸20ml,迅速搅拌,并密闭70℃保温30min滤过,用水洗涤滤饼,干燥,得木犀草素7.5g,经HPLC测定,纯度98.1%。1H-NMR(DMSO d6,400MHz):δ7.41(1H,bd,J=8.4 Hz,H 6'),7.39(1H,bs,H2'),6.89(1H,d,J=8.4 Hz,H 5'),6.61(1H,s,H3),6.44(1H,d,J=2 Hz,H 8),6.19(1H,d,J=2Hz,H 6);13C-NMR(DMSO d6,100 MHz):δ182.1(C-4),164.5(C-7),164.4(C-2),161.9(C-5),157.7(C-9),150.1(C-4′),146.2(C-3′),122.0(C-1′),119.4(C-6′),116.5(C-5′),113.8(C-2′),104.2(C-10),103.3(C-3),99.3(C-6)94.3(C-8);EIMS(40eV.):m/z%286(100),152(10)137(15);UVλmax nm in MeOH:346,258;+NaOMe 407,267;+AlCl3422,320sh,265;+AlCl3/HCl 390,375,273。 Quickly weigh anhydrous aluminum trichloride (AR) 3.5g in a 250ml iodine volumetric flask, quickly add 15ml of pyridine (AR), shake well, add methanol (AR) 8ml, 2min, add 98% hesperetin 8.5g Stir for 5min, add iodine (AR) 6.8g, add 7ml of methanol (AR), stir for 3min, end the iodine bottle with a condenser or air condensing tube, and seal at 80 °C (to prevent absorption of moisture in the air) every 1h After stirring for 1 time, a homogeneous solution was formed after 2 hours, and the closed reaction was continued for 6 hours (dehydrogenation was completed). In an air bath, sealed at 113 ° C for 15 h (demethylation reaction, the solution changed from solution to solid, soft when hot, very hard when cooled), placed at 80 ° C. The distillate was poured into an iodine measuring flask and incubated at 80 ° C for 3 h. The solid was converted into a solution, and then sealed in an air bath at 116 ° C for 15 h (second demethylation), placed at 80 ° C, and added with 100 ml of ethanol. Dissolve, quickly add 20 ml of phosphoric acid, stir rapidly, and filter at 70 ° C for 30 min. The filter cake was washed with water and dried to obtain 7.5 g of luteolin. The purity was 98.1% by HPLC. 1 H-NMR (DMSO d6, 400 MHz): δ 7.41 (1H, bd, J = 8.4 Hz, H 6 '), 7.39 (1H, bs, H2'), 6.89 (1H, d, J = 8.4 Hz, H 5 '), 6.61 (1H, s, H 3 ), 6.44 (1H, d, J = 2 Hz, H 8), 6.19 (1H, d, J = 2 Hz, H 6); 13 C-NMR (DMSO) D6,100 MHz): δ182.1 (C-4), 164.5 (C-7), 164.4 (C-2), 161.9 (C-5), 157.7 (C-9), 150.1 (C-4') , 146.2 (C-3'), 122.0 (C-1'), 119.4 (C-6'), 116.5 (C-5'), 113.8 (C-2'), 104.2 (C-10), 103.3 ( C-3), 99.3 (C-6) 94.3 (C-8); EIMS (40 eV.): m/z% 286 (100), 152 (10) 137 (15); UV λ max nm in MeOH: 346, 258; NaOMe 407, 267; + AlCl 3 422, 320 sh, 265; + AlCl 3 / HCl 390, 375, 273.

Claims (8)

  1. 木犀草素、木犀草苷、木犀草素芸香糖苷半合成的方法,具体特征在于A、B、C三条途径:A途径:吡啶类、三价铝离子化合物、低沸点的醇、橙皮素、碘混合,在20-110℃加热反应脱氢,形成均一液,PC/TLC/HPLC跟踪起始产物脱氢完全;然后在80℃-180℃密闭蒸馏2-80h,PC/TLC/HPLC跟踪检查脱甲基产物(当一次密闭蒸馏脱甲基不完全时,可将蒸馏液倒入反应器中,经加热搅拌溶解,再进行密闭蒸馏,可提高脱甲基产物的收率),将蒸馏产物加醇加热溶解,加入磷酸,析出木犀草素;A method for semi-synthesis of luteolin, luteolin, and luteolin rutinoside, specifically characterized by three pathways A, B, and C: A pathway: pyridine, trivalent aluminum ion compound, low boiling alcohol, hesperetin, Iodine mixing, dehydrogenation by heating at 20-110 °C to form a homogenous liquid, PC/TLC/HPLC to trace the dehydrogenation of the starting product completely; then sealed at 80 ° C -180 ° C for 2-80 h, PC / TLC / HPLC follow-up inspection Demethylation product (when the demethylation in a closed distillation is incomplete, the distillate can be poured into the reactor, dissolved by heating, and then subjected to closed distillation to increase the yield of the demethylated product), and the distillation product is obtained. Add alcohol to dissolve, add phosphoric acid, and precipitate luteolin;
    B途径:吡啶类、三价铝离子化合物、低沸点的醇、橙皮素-7-O-葡萄糖苷、碘混合,在20-110℃加热反应脱氢,形成均一液,PC/TLC/HPLC跟踪起始产物脱氢完全;然后在80℃-180℃密闭蒸馏2-80h,PC/TLC/HPLC跟踪检查脱甲基产物,将蒸馏产物加醇加热溶解,加入磷酸,析出木犀草苷和香叶木素-7-O-葡萄糖苷,经层析分离可得木犀草苷和香叶木素-7-O-葡萄糖苷;Route B: pyridine, trivalent aluminum ion compound, low boiling point alcohol, hesperetin-7-O-glucoside, iodine mixed, dehydrogenation by heating at 20-110 ° C to form a homogeneous solution, PC / TLC / HPLC The starting product is completely dehydrogenated; then it is sealed and sealed at 80 ° C - 180 ° C for 2-80 h. The demethylation product is traced by PC/TLC/HPLC. The distilled product is heated and dissolved by alcohol, and phosphoric acid is added to precipitate luteolin and geranium. -7-7-O-glucoside, which can be obtained by chromatography to obtain luteolin and geranyl-7-O-glucoside;
    C途径:吡啶类、三价铝离子化合物、低沸点的醇、橙皮苷、碘混合,在20-110℃加热反应脱氢,形成均一液,PC/TLC/HPLC跟踪起始产物脱氢完全;然后在80℃-180℃密闭蒸馏2-80h,PC/TLC/HPLC跟踪检查脱甲基产物,将蒸馏产物加醇加热溶解,加入磷酸,析出沉淀(地奥明),滤过,得木犀草素-7-芸香苷的酸水液:通过大孔吸附树脂吸附,水洗脱除杂,乙醇洗脱,回收乙醇,可得木犀草素-7-芸香糖苷;木犀草素-7-芸香苷的酸水液通过酸水解,可得木犀草素及木犀草苷混合物,经硅胶柱层析分离可得木犀草苷及木犀草素单体;木犀草素-7-芸香苷的酸水液在醇中完全水解,可得木犀草素。Route C: pyridine, trivalent aluminum ion compound, low boiling point alcohol, hesperidin, iodine mixed, dehydrogenation by heating at 20-110 ° C to form a homogenous liquid, PC/TLC/HPLC to trace the dehydrogenation of the starting product completely Then, it is sealed and sealed at 80 ° C - 180 ° C for 2 - 80 h. The demethylation product is traced by PC/TLC/HPLC. The distilled product is heated and dissolved by alcohol, phosphoric acid is added, and the precipitate is precipitated (Dioxing). Oxalate-7-rutinoside acid solution: adsorption by macroporous adsorption resin, water elution and impurity removal, ethanol elution, recovery of ethanol, luteolin-7-rutinoside; luteolin-7-rutin The acid water solution can be obtained by acid hydrolysis, and a mixture of luteolin and luteolin can be obtained, and the luteolin and luteolin monomers can be obtained by silica gel column chromatography; the acid water of luteolin-7-rutinoside is obtained. Fully hydrolyzed in the alcohol to obtain luteolin.
  2. 如权利1要求所述,其特征在于:在本发明所说的吡啶类,主要指吡啶、2-甲基吡啶、3-甲基吡啶、4-甲基吡啶、4-甲基吡啶、5-甲基吡啶、6-甲基吡啶、2,6-二甲基吡啶、3,5-二甲基吡啶、2,4,6-三甲基吡啶,其中优选吡啶。According to claim 1, it is characterized in that the pyridines in the present invention mainly refer to pyridine, 2-methylpyridine, 3-methylpyridine, 4-methylpyridine, 4-methylpyridine, 5- Methylpyridine, 6-methylpyridine, 2,6-lutidine, 3,5-lutidine, 2,4,6-trimethylpyridine, of which pyridine is preferred.
  3. 如权利1要求所述,其特征在于:在本发明所说的三价铝离子化合物,主要指三氯化铝、三溴化铝、三碘化铝,甲醇铝、乙醇铝、丙醇铝等,优先选择无水三氯化铝,其中卤化铝:橙皮苷(或橙皮素或橙皮素-7-O-葡萄糖苷)的摩尔比在3:1-1:3,优先为1:1。According to claim 1, it is characterized in that the trivalent aluminum ion compound in the present invention mainly refers to aluminum trichloride, aluminum tribromide, aluminum triiodide, aluminum methoxide, aluminum ethoxide, aluminum propoxide, and the like. Preferred is anhydrous aluminum trichloride, wherein the molar ratio of aluminum halide: hesperidin (or hesperetin or hesperetin-7-O-glucoside) is from 3:1 to 1:3, with a priority of 1: 1.
  4. 如权利1要求所述,其特征在于:在本发明所说的低沸点醇,指甲醇、乙醇、 丙醇、异丙醇,用量其中优选甲醇,其甲醇用量以体积计,不超过吡啶类用量体积。According to claim 1, it is characterized in that the low boiling point alcohol in the present invention means methanol, ethanol, Propanol, isopropanol, the amount of methanol is preferred, and the amount of methanol used is not more than the volume of the pyridine.
  5. 如权利1要求所述,其特征在于:在本发明所说的橙皮苷(CAS:520-26-3)、橙皮素(CAS:520-33-2)、橙皮素-7-O-葡萄糖苷(CAS:31712-49-9,结构如(A))作为脱氢脱甲起始反应物,其中橙皮苷(或橙皮素或橙皮素-7-O-葡萄糖苷):吡啶类的摩尔比在1:5-1:10,优选为1:6-1:7。According to claim 1, it is characterized by the hesperidin (CAS: 520-26-3), hesperetin (CAS: 520-33-2), and hesperetin-7-O according to the present invention. - Glucosin (CAS: 31712-49-9, structure (A)) as a dehydrogenation and de-starting reactant, wherein hesperidin (or hesperetin or hesperetin-7-O-glucoside): The molar ratio of the pyridines is from 1:5 to 1:10, preferably from 1:6 to 1:7.
    Figure PCTCN2015073238-appb-100001
    Figure PCTCN2015073238-appb-100001
  6. 如权利1要求所述,其特征在于:在本发明所说的碘、其用量与橙皮素(或橙皮苷、或橙皮素-7-O-葡萄糖苷)摩尔比优选1:1。It is characterized in that, in the present invention, the iodine, the amount thereof and the hesperetin (or hesperidin or hesperetin-7-O-glucoside) molar ratio are preferably 1:1.
  7. 如权利1要求所述,其特征在于:在本发明所说的密闭蒸馏,指蒸馏温度在80℃-180℃,优选90℃-150℃,密闭指在蒸馏过程中,外界空气不能进入反应器中,但反应器中空气可排出,醇及吡啶类蒸汽可被冷凝排出。According to claim 1, it is characterized in that the closed distillation in the present invention means that the distillation temperature is in the range of 80 ° C to 180 ° C, preferably 90 ° C to 150 ° C. The sealing means that outside air cannot enter the reactor during the distillation process. Medium, but the air in the reactor can be discharged, and the alcohol and pyridine vapor can be condensed and discharged.
  8. 如权利1要求所述,其特征在于:本发明所说的木犀草素(CAS:491-70-3)、木犀草苷(CAS:5373-11-5)、木犀草素-7-O-芸香糖苷(CAS:20633-84-5,结构如(B))分别系脱氢脱甲基于一步法制备。According to claim 1, it is characterized by: luteolin (CAS: 491-70-3), luteolin (CAS: 5373-11-5), luteolin-7-O- as described in the present invention. The rutinoside (CAS: 20633-84-5, structure (B)) was prepared by one-step dehydrogenation and demethylation, respectively.
    Figure PCTCN2015073238-appb-100002
    Figure PCTCN2015073238-appb-100002
PCT/CN2015/073238 2014-02-23 2015-02-21 Semi-synthesis method for luteolin, galuteolin and luteolin rutinoside WO2015124113A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201410059639.7 2014-02-23
CN201410059639.7A CN103833714B (en) 2014-02-23 2014-02-23 Luteolin, luteoloside, the semisynthetic method of luteolin rutinoside

Publications (1)

Publication Number Publication Date
WO2015124113A1 true WO2015124113A1 (en) 2015-08-27

Family

ID=50797653

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2015/073238 WO2015124113A1 (en) 2014-02-23 2015-02-21 Semi-synthesis method for luteolin, galuteolin and luteolin rutinoside

Country Status (2)

Country Link
CN (1) CN103833714B (en)
WO (1) WO2015124113A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117330677A (en) * 2023-11-24 2024-01-02 成都凡微析医药科技有限公司 Quantitative detection method of myrosin and hesperetin for bioequivalence study of citrus flavone tablet

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103833714B (en) * 2014-02-23 2016-07-13 闻永举 Luteolin, luteoloside, the semisynthetic method of luteolin rutinoside
CN104327136A (en) * 2014-11-19 2015-02-04 陕西嘉禾植物化工有限责任公司 Preparation method of eriocitrin
CN106278825B (en) * 2016-08-12 2019-01-11 荆楚理工学院 A kind of ether bond rupture method of o-hydroxy-phenyl alkyl ether
CN112851616B (en) * 2021-01-25 2023-09-26 三原润禾生物科技有限公司 Semisynthesis method of eriodictyol

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031430A2 (en) * 2001-10-04 2003-04-17 Brane Tech S.R.L. Flavonoid compounds and their pharmaceutical uses
CN1544427A (en) * 2003-11-20 2004-11-10 黑龙江大学 Luteolin semi-synthesis method
CN103145668A (en) * 2013-01-07 2013-06-12 李玉山 New technology for preparing luteolin by using hesperidin
CN103145670A (en) * 2013-01-21 2013-06-12 李玉山 Semisynthesis luteolin preparation new process
WO2013111148A1 (en) * 2011-12-13 2013-08-01 Laurus Labs Private Limited Process for preparation of luteolin
CN103833714A (en) * 2014-02-23 2014-06-04 闻永举 Semi-synthesis method of luteolin and galuteolin as well as luteolin rutinoside

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1297552C (en) * 2004-03-11 2007-01-31 南京莱尔生物化工有限公司 Process for synthesizing luteolin

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031430A2 (en) * 2001-10-04 2003-04-17 Brane Tech S.R.L. Flavonoid compounds and their pharmaceutical uses
CN1544427A (en) * 2003-11-20 2004-11-10 黑龙江大学 Luteolin semi-synthesis method
WO2013111148A1 (en) * 2011-12-13 2013-08-01 Laurus Labs Private Limited Process for preparation of luteolin
CN103145668A (en) * 2013-01-07 2013-06-12 李玉山 New technology for preparing luteolin by using hesperidin
CN103145670A (en) * 2013-01-21 2013-06-12 李玉山 Semisynthesis luteolin preparation new process
CN103833714A (en) * 2014-02-23 2014-06-04 闻永举 Semi-synthesis method of luteolin and galuteolin as well as luteolin rutinoside

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117330677A (en) * 2023-11-24 2024-01-02 成都凡微析医药科技有限公司 Quantitative detection method of myrosin and hesperetin for bioequivalence study of citrus flavone tablet
CN117330677B (en) * 2023-11-24 2024-02-23 成都凡微析医药科技有限公司 Quantitative detection method of myrosin and hesperetin for bioequivalence study of citrus flavone tablet

Also Published As

Publication number Publication date
CN103833714A (en) 2014-06-04
CN103833714B (en) 2016-07-13

Similar Documents

Publication Publication Date Title
Okuda et al. Tannis of Casuarina and Stachyurus species. Part 1. Structures of pendunculagin, casuarictin, strictinin, casuarinin, casuariin, and stachyurin
US3524844A (en) Epipodophyllotoxin glucoside derivatives
WO2015124113A1 (en) Semi-synthesis method for luteolin, galuteolin and luteolin rutinoside
YOSHIDA et al. Woodfordin C, a macro-ring hydrolyzable tannin dimer with antitumor activity, and accompanying dimers from Woodfordia fruticosa flowers
US10196417B2 (en) Baicalin magnesium compound and its preparation method and application
CN102875511B (en) Method for comprehensively extracting dye lignin and kaempferol from sophora fruit
CN104151373A (en) Lignan glycoside compounds and preparation method thereof
CN103665082B (en) Hemsleya cucurbitane tetracyclic triterpenoid compound, pharmaceutical compositions containing same and application of compound and pharmaceutical composition
Jurd Plant polyphenols. V. Selective alkylation of the 7-hydroxyl group in polyhydroxyflavones
Jiang et al. Phenolic glycosides from Ficus tikoua and their cytotoxic activities
CN104529983B (en) Corm Eleocharitis skin extracts the method for eriodictyol
CN103145670A (en) Semisynthesis luteolin preparation new process
CN103626824B (en) Hemsleya amabilis cucurbitane tetracyclic triterpene compound, pharmaceutical composition comprising compound and application of pharmaceutical composition and compound
CN108864008B (en) Aurone compound and preparation method and application thereof
CN106928170B (en) Dihydrofuranbiphenyl compound and preparation method and application thereof
Ahmed et al. Antioxidant activity with flavonoidal constituents from Aerva persica
CN113429452B (en) Acylated mogroside derivatives as anti-inflammatory agents and anti-inflammatory compositions
CN115286606A (en) Gastrodia elata flavonoid compound and preparation method and application thereof
CN108929220A (en) A kind of preparation method of gallic acid
NO142786B (en) PROCEDURE FOR PREPARING DIOSMIN.
CN102618593B (en) Method for preparing scutellarin by using Aspergillus niger AS 3.795 for hydrolyzing scutellarin-7-O-glucuronide
King et al. Unusual production of 5-nitroanthranilic acid by Streptomyces scabies
CN116270790B (en) Preparation method of momordica grosvenori stem extract
CN104447330A (en) Method for preparing antibacterial agent from pine needles
CN108329369B (en) Preparation method of high-content rutin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15752082

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15752082

Country of ref document: EP

Kind code of ref document: A1